Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Smedby KE et al. – The number of patients admitted with BM has increased rapidly in Sweden. In spite of recent improvements in the prognosis of common primary cancer types, any parallel improvement among patients with advanced cancer and BM is not indicated.

Related Articles

Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT)
Annals of Oncology, 10/21/09    Relevance Score: 71%

Incidence of brain metastases in renal cell carcinoma treated with sorafenib
Annals of Oncology, 10/29/09    Relevance Score: 69%

Reirradiation for progressive brain metastases
Journal of Cancer Research and Therapeutics, 10/27/09    Relevance Score: 69%

Clinical Analysis of Novalis Stereotactic Radiosurgery for Brain Metastases
Journal of Korean Neurosurgical Society, 10/30/09    Relevance Score: 68%

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
The Lancet Oncology - Online First, 10/07/09    Relevance Score: 68%

Today in Neurologic Oncology...keeping you current

KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma
Clinical Cancer Research, 12/01/09

High-risk neuroblastoma: a therapy in evolution
Pediatric Hematology and Oncology, 11/30/09

Role of caspase 8 as a determinant in trail sensitivity of neuroblastoma cell lines
Pediatric Hematology and Oncology, 11/30/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address